BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Samonakis DN, Kouroumalis EA. Systemic treatment for hepatocellular carcinoma: Still unmet expectations. World J Hepatol 2017; 9(2): 80-90 [PMID: 28144389 DOI: 10.4254/wjh.v9.i2.80] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Xu Z, Yan S, Wu H, Zhang Y, Wei W. Angiotensin II and tumor necrosis factor-α stimulate the growth, migration and invasion of BEL-7402 cells via down-regulation of GRK2 expression. Digestive and Liver Disease 2019;51:263-74. [DOI: 10.1016/j.dld.2018.06.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Su ZL, Su CW, Huang YL, Yang WY, Sampurna BP, Ouchi T, Lee KL, Wu CS, Wang HD, Yuh CH. A Novel AURKA Mutant-Induced Early-Onset Severe Hepatocarcinogenesis Greater than Wild-Type via Activating Different Pathways in Zebrafish. Cancers (Basel) 2019;11:E927. [PMID: 31269749 DOI: 10.3390/cancers11070927] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
3 Li Y, Han Q, Zhao H, Guo Q, Zhang J. Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular Carcinoma. Front Pharmacol 2020;11:597520. [PMID: 33343368 DOI: 10.3389/fphar.2020.597520] [Reference Citation Analysis]
4 Wang Z, Han YJ, Huang S, Wang M, Zhou WL, Li HS, Wang QS, Wu HB. Imaging the expression of glypican-3 in hepatocellular carcinoma by PET. Amino Acids 2018;50:309-20. [PMID: 29204748 DOI: 10.1007/s00726-017-2517-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
5 Chen YC, Chen IS, Huang GJ, Kang CH, Wang KC, Tsao MJ, Pan HW. Targeting DTL induces cell cycle arrest and senescence and suppresses cell growth and colony formation through TPX2 inhibition in human hepatocellular carcinoma cells. Onco Targets Ther 2018;11:1601-16. [PMID: 29606879 DOI: 10.2147/OTT.S147453] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
6 Wang B, Xu J, Wang H, Chang S, Liu N. Effect and Mechanism of Sophoridine to suppress Hepatocellular carcinoma in vitro and vivo. Biomed Pharmacother 2017;95:324-30. [PMID: 28858730 DOI: 10.1016/j.biopha.2017.08.029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
7 Walter I, Schulz U, Vogelhuber M, Wiedmann K, Endlicher E, Klebl F, Andreesen R, Herr W, Ghibelli L, Hackl C, Wiest R, Reichle A. Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial. Med Oncol 2017;34:192. [PMID: 29098441 DOI: 10.1007/s12032-017-1040-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
8 Radwan RR, Ali HE. Radiation-synthesis of chitosan/poly (acrylic acid) nanogel for improving the antitumor potential of rutin in hepatocellular carcinoma. Drug Deliv Transl Res 2021;11:261-78. [PMID: 32488816 DOI: 10.1007/s13346-020-00792-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Ezhuthupurakkal PB, Ariraman S, Arumugam S, Subramaniyan N, Muthuvel SK, Kumpati P, Rajamani B, Chinnasamy T. Anticancer potential of ZnO nanoparticle-ferulic acid conjugate on Huh-7 and HepG2 cells and diethyl nitrosamine induced hepatocellular cancer on Wistar albino rat. Nanomedicine 2018;14:415-28. [PMID: 29166623 DOI: 10.1016/j.nano.2017.11.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
10 Ali MM, H Borai I, Ghanem HM, H Abdel-Halim A, Mousa FM. The prophylactic and therapeutic effects of Momordica charantia methanol extract through controlling different hallmarks of the hepatocarcinogenesis. Biomed Pharmacother 2018;98:491-8. [PMID: 29287196 DOI: 10.1016/j.biopha.2017.12.096] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
11 Chen Y, Zhang J, Liu M, Zou Z, Wang F, Hu H, Sun B, Zhang S. Risk of Developing Hepatocellular Carcinoma following Depressive Disorder Based on the Expression Level of Oatp2a1 and Oatp2b1. Biomed Res Int 2019;2019:3617129. [PMID: 31467884 DOI: 10.1155/2019/3617129] [Reference Citation Analysis]
12 Desai A, Sandhu S, Lai JP, Sandhu DS. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World J Hepatol 2019; 11(1): 1-18 [PMID: 30705715 DOI: 10.4254/wjh.v11.i1.1] [Cited by in Crossref: 77] [Cited by in F6Publishing: 59] [Article Influence: 25.7] [Reference Citation Analysis]
13 Yang WY, Rao PS, Luo YC, Lin HK, Huang SH, Yang JM, Yuh CH. Omics-based Investigation of Diet-induced Obesity Synergized with HBx, Src, and p53 Mutation Accelerating Hepatocarcinogenesis in Zebrafish Model. Cancers (Basel) 2019;11:E1899. [PMID: 31795276 DOI: 10.3390/cancers11121899] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
14 Eroğlu Gülümsek Ö, Erciyas Baykal E, Küçükpolat C, Önal E, Balcik-ercin P, Yagci T, Ahsen V, Gürek AG. Bis[ N,N′ -bis(anilino)glioximato]platinum(II) complex: synthesis, characterization and biological activity. Journal of Coordination Chemistry. [DOI: 10.1080/00958972.2022.2028779] [Reference Citation Analysis]
15 Fukuyama K, Asagiri M, Sugimoto M, Tsushima H, Seo S, Taura K, Uemoto S, Iwaisako K. Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clusters. PLoS One 2021;16:e0245939. [PMID: 33539378 DOI: 10.1371/journal.pone.0245939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Chen L, Jin T, Ning C, Wang S, Wang L, Lin J. [Anti-tumor and immune-modulating effect of Jiawei Sijunzi decoction in mice bearing hepatoma H22 tumor]. Nan Fang Yi Ke Da Xue Xue Bao 2019;39:241-8. [PMID: 30890515 DOI: 10.12122/j.issn.1673-4254.2019.02.18] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Nguyen L, Chapel S, Tran BD, Lacy S. Cabozantinib exposure-response analyses of efficacy and safety in patients with advanced hepatocellular carcinoma. J Pharmacokinet Pharmacodyn 2019;46:577-89. [PMID: 31637577 DOI: 10.1007/s10928-019-09659-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
18 Qin S, Finn RS, Kudo M, Meyer T, Vogel A, Ducreux M, Macarulla TM, Tomasello G, Boisserie F, Hou J, Li X, Song J, Zhu AX. RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma. Future Oncol 2019;15:1811-22. [PMID: 30969136 DOI: 10.2217/fon-2019-0097] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 9.7] [Reference Citation Analysis]
19 Ceballos MP, Rigalli JP, Ceré LI, Semeniuk M, Catania VA, Ruiz ML. ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma. Curr Med Chem 2019;26:1224-50. [PMID: 29303075 DOI: 10.2174/0929867325666180105103637] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
20 Subramaniyam N, Arumugam S, Ezthupurakkal PB, Ariraman S, Biswas I, Muthuvel SK, Balakrishnan A, Alshammari GM, Chinnasamy T. Unveiling anticancer potential of glibenclamide: Its synergistic cytotoxicity with doxorubicin on cancer cells. Journal of Pharmaceutical and Biomedical Analysis 2018;154:294-301. [DOI: 10.1016/j.jpba.2018.03.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
21 Chowdhury KD, Sarkar A, Chatterjee S, Patra D, Sengupta D, Banerjee S, Chakraborty P, Sadhukhan GC. Cathepsin B mediated scramblase activation triggers cytotoxicity and cell cycle arrest by andrographolide to overcome cellular resistance in cisplatin resistant human hepatocellular carcinoma HepG2 cells. Environ Toxicol Pharmacol 2019;68:120-32. [PMID: 30889542 DOI: 10.1016/j.etap.2019.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
22 Talaat RM, Abo-Zeid TM, Abo-Elfadl MT, El-Maadawy EA, Hassanin MM. Combined Hyperthermia and Radiation Therapy for Treatment of Hepatocellular Carcinoma. Asian Pac J Cancer Prev 2019;20:2303-10. [PMID: 31450899 DOI: 10.31557/APJCP.2019.20.8.2303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]